Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 May:123:87-91.
doi: 10.1016/j.jhin.2022.03.001. Epub 2022 Mar 12.

Airborne SARS-CoV-2 RNA excretion by patients with COVID-19 on different oxygen-delivery systems: a prospective observational study

Affiliations
Observational Study

Airborne SARS-CoV-2 RNA excretion by patients with COVID-19 on different oxygen-delivery systems: a prospective observational study

M L Janssen et al. J Hosp Infect. 2022 May.

Abstract

Background: Concerns persist regarding the risk of airborne SARS-CoV-2 transmission by patients with COVID-19 on various modalities of oxygen therapy, such as high-flow nasal cannula (HFNC).

Aim: We aimed to compare the presence of airborne RNA in air samples between groups of patients with COVID-19 on different oxygen-delivery systems. We also explored factors that were associated with SARS-CoV-2 RNA positivity in air samples.

Results: Air samples were positive for SARS-CoV-2 RNA in three of 39 patients (8%) on HFNC, 0 of 13 (0%) on masks, versus five of 20 (25%) on nasal cannula. Odds ratio for air sample positivity was 0.52 (95% confidence interval (CI) 0.11-2.34) when comparing HFNC vs non-HFNC group, and 5.78 (1.24-27.01) for nasal cannula vs non-nasal cannula group. Patients with positive air samples in comparison with those with negative air samples were sampled earlier after symptoms onset (median: 7 vs 10 days; P=0.04) and had lower Ct values of diagnostic nasopharyngeal samples (median: 22 vs 26; P=0.02).

Conclusions: Air sample positivity was not related to oxygen support device but to viral load. These data suggest that the use of personal protection equipment should be based on risk management according to viral load rather than oxygen support device.

Keywords: Air sampling; COVID-19; High-flow nasal cannula; SARS-CoV-2; Viral load.

PubMed Disclaimer

References

    1. Ferioli M., Cisternino C., Leo V., Pisani L., Palange P., Nava S. Protecting healthcare workers from SARS-CoV-2 infection: practical indications. Eur Respir Rev. 2020;29(155) - PMC - PubMed
    1. Ospina-Tascon G.A., Calderon-Tapia L.E., Garcia A.F., Zarama V., Gomez-Alvarez F., Alvarez-Saa T., et al. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA. 2021;326(21):2161–2171. - PMC - PubMed
    1. Gaeckle NTLJP Y., Kreykes G., Evans M.D., Hogan C.J., Jr. Aerosol generation from the respiratory tract with various modes of oxygen delivery. Am J Respir Crit Care Med. 2020;202(8):1115–1124. - PMC - PubMed
    1. de Man P., Ortiz M., Bluyssen P.M., de Man S.J., Rentmeester M.J., van der Vliet M., et al. Airborne SARS-CoV-2 in home- and hospital environment investigated with a high-powered air sampler. J Hosp Infect. 2021;119:126–131. - PMC - PubMed
    1. Knight S.R., Ho A., Pius R., Buchan I., Carson G., Drake T.M., et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339. - PMC - PubMed

Publication types